Thu, Jul 10, 2014, 2:54 PM EDT - U.S. Markets close in 1 hr 6 mins


% | $
Quotes you view appear here for quick access.

Krispy Kreme Doughnuts, Inc. Message Board

skiidady6 2 posts  |  Last Activity: Jul 8, 2014 8:13 AM Member since: Oct 28, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Together with the forthcoming european licenses that turdboy predicted in early March to be issued "within weeks" will put ACCP heavily in the black.......don't you agree???

  • "As of May 12, 2014, we did not have enough capital to achieve our long-term goals. A failure to obtain necessary additional capital in the future could jeopardize our operations and our ability to continue as a going concern.

    We have incurred negative cash flows from operations since inception, and have expended, and expect to continue to expend in the future, substantial funds to complete our planned product development efforts. Since inception, our expenses have significantly exceeded revenues, resulting in an accumulated deficit as of March 31, 2014 of $268,005,000. We expect that our capital resources, royalties from MuGard and expected receipts due under our license agreements will be adequate to fund our current level of operations for the next twelve months. However, our ability to fund operations over this time could change significantly depending upon changes to future operational funding obligations or capital expenditures. As a result, we may be required to seek additional financing sources within the next twelve months. We cannot provide assurance that we will ever be able to generate sufficient product revenue or royalty revenue to achieve profitability on a sustained basis or at all.

    Since our inception, we have devoted our resources primarily to fund our research and development programs. We have been unprofitable since inception and to date have received limited revenues from the sale of products. We expect to incur losses for the next several years as we continue to invest in product research and development, preclinical studies, clinical trials and regulatory compliance.

    Net loss allocable to common stockholders for the first quarter of 2014 was $1,584,000, or a $0.06 basic and diluted loss per common share as compared to a net income of $3,354,000, or a $0.14 basic income per common share and a $0.13 diluted income per common share, for the same period in 2013, an increased loss of $4,938,000."

15.65-0.13(-0.82%)2:51 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.